A pilot randomized controlled trial of liraglutide 3.0 mg for binge eating disorder.

Obes Sci Pract · 2023 · PMC10073825 · PMID 37034559

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The liraglutide group had somewhat larger reductions in BMI and waist circumference, but the between‐group differences in those outcomes did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.